NEI Research News

The National Eye Institute (NEI), a part of the Federal government’s National Institutes of Health, recently published its latest planning document, National Plan for Eye and Vision Research. 

An important clinical trial, sponsored by the National Eye Institute(NEI), a part of the National Institutes of Health (NIH), has provided doctors with improved prognostic indicators and treatment options for retinopathy of prematurity.

Prescribing six hours of daily patching for the unaffected eye of children with severe amblyopia works as well as prescribing full-time patching.

Patching the unaffected eye of children with moderate amblyopia for two hours daily works as well as patching the eye for six hours.

Researchers have found that the three-year progression of myopia (nearsightedness) in a large group of ethnically diverse children who wore progressive addition lenses (PALs or no-line bifocals) was slightly less than that of children who wore single...

Researchers have found that immediately treating people who have early stage glaucoma can delay progression of the disease.

Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma.

More Americans than ever are facing the threat of blindness from age-related eye disease, a new report says. Over one million Americans aged 40 and over are currently blind and an additional 2.4 million are visually impaired.

Atropine eye drops given once a day to treat amblyopia, or lazy eye, the most common cause of visual impairment in children, work as well as the standard treatment of patching one eye.

Researchers report that the overall prevalence of glaucoma in Mexican-Americans is between reported rates for Blacks and Whites.